Trial intelligence / Profile preview

Phase II dasatinib ± fludarabine in fludarabine-refractory CLL

2008-002236-15Phase 2Active

Sponsor

Academic Medical Center

Start

Jun 2008

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1